Technology, Healthcare Feb 21, 2022 08:19 AM (GMT+8) · EqualOcean
In February 21st, the pharmaceutical company and pharmaceutical company jointly announced the signing of a commercial production cooperation agreement for dorzagliatin, the world's first new oral medicine for type 2 diabetes. According to the cooperation agreement, the two sides will continue to strengthen cooperation in the R & D and commercial production of API and solid dispersion.
Related companies: